OBGYN.net Osteoporosis
Articles for the Medical Professional
Text Articles
Prevent Osteoporosis Before it is Too Late - Robert Mascitelli, MD
Osteoporosis Medications and Prevention - Andrew Dott, MD, MPH and Anthony Karpas MD
Osteoporosis - By: Bradley G. Goldberg, M.D.
Research & Abstracts
An Overlooked Connection: Serotonergic Mediation of Estrogen-related Physiology and Pathology - L. A. Rybaczyk, M. J. Bashaw, D. R. Pathak, S. M. Moody, R. M. Gilders & D. L. Holzschu
Assessment of Soy Phytoestrogens' Effects on Bone Turnover Indicators in Menopausal Women with Osteopenia in Iran: A Before and After Clinical Trial - A. H. Roudsari, F. Tahbaz, A. Hossein-Nezhad, B. Arjmandi, B. Larijani & S. Masoud Kimiagar
An Increase in Dietary n-3 Fatty Acids Decreases a Marker of Bone Resorption in Humans - A. E. Griel, P. M Kris-Etherton, K. F. Hilpert, G. Zhao, S. G. West & R. L. Corwin
Discordance in Diagnosis of Osteoporosis using Spine and Hip Bone Densitometry - A. Moayyeri1, A. Soltani, N. K. Tabari, M. Sadatsafavi, A. Hossein-neghad & B. Larijani
Direct Effects of Caffeine on Osteoblastic Cells Metabolism: The Possible Causal Effect of Caffeine on the Formation of Osteoporosis - Yang-Hwei Tsuang, Jui-Sheng Sun, Li-Ting Chen, Samuel Chung-Kai Sun & San-Chi Chen
Do Patients Receive Recommended Treatment of Osteoporosis Following Hip Fracture in Primary Care? - R. J. Petrella & T. J. Jones
Evaluation of Easily Measured Risk Factors in the Prediction of Osteoporotic Fractures - R. Bensen, J. D. Adachi, A. Papaioannou, G. Ioannidis, W. P. Olszynski, R. J. Sebaldt, T. M. Murray, R. G. Josse, J. P. Brown, D. A. Hanley, A. Petrie, M. Puglia, C. H. Goldsmith & W. Bensen
Gene Expression Analysis in Human Osteoblasts Exposed to Dexamethasone Identifies Altered Developmental Pathways as Putative Drivers of Osteoporosis - C. J. Hurson, J. S. Butler, D. T. Keating, D. W. Murray, D. M. Sadlier, J. M. O'Byrne and P. P. Doran
Hypertensive Crisis Associated with High Dose Soy Isoflavone Supplementation in a Post-menopausal Woman: A Case Report [ISRCTN98074661] - A. M. Hutchins , I. E. McIver & C. S. Johnston
Patient Advocacy: Barriers and Facilitators - R. Negarandeh, F. Oskouie, F. Ahmadi, M. Nikravesh & I. Rahm Hallberg
The Impact of Vitamin D Status on Changes in Bone Mineral Density During Treatment with Bisphosphonates and After Discontinuation Following Long-term Use in Post-menopausal Osteoporosis - A. Deane, L. Constancio, I. Fogelman and G. Hampson
The Effect on Behavior and Bone Mineral Density of Individualized Bone Mineral Density Feedback and Educational Interventions in Premenopausal Women: A Randomized Controlled Trial [NCT00273260] - T. Winzenberg, B. Oldenburg, S. Frendin, L. De Wit, M. Riley & G. Jones
Timing and Risk Factors for Clinical Fractures Among Postmenopausal Women: A 5-year Prospective Study - A. CM van Geel, P. P. Geusens, I. F. Nagtzaam, C. MJR Schreurs, D. JM van der Voort, P. ELM Rinkens, A. DM Kester & Geert-Jan Dinant
The Effects of Organic Nitrates on Osteoporosis: A Randomized Controlled Trial [ISRCTN94484747] - S. A. Jamal, C. J. Hamilton, D. Black & S. R. Cummings
Perimenopausal and Postmenopausal Health - Cheung, Chaudhry, Kapral, Jackevicius & Robinson
Quality of Life in Post-Menopausal Osteoporosis - M. L. Bianchi, M. R. Orsini, S. Saraifoger, S. Ortolani, G. Radaelli & S. Betti
AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis - Developed by The American Association of Clinical Endocrinologists and The American College of Endocrinology. Reprinted with permission from AACE.
Bone Remodeling - Bone is continuously remodeled through a coupled process of bone resorption and formation.
Brochure on Osteoporosis & Bone Health - R. W. Whitted, M.D., M.P.H
Fast Facts on Osteoporosis - Susan G. Hill, APR"Assessing Bone Resorption Levels to Predict Skeletal Responses to HRT" - Ian H. Thorneycroft, PhD, MD
Two-Thirds of American Women Age 40 and Over Don’t Know Much About Sex Hormones
Results of Yankelovich/University of Cincinnati Survey
Lactose Intolerance and Bone Health
Hormone Replacement Therapy in Postmenopausal Women: Urinary N-Telopeptide of Type I Collagen Monitors Therapeutic Effect and Predicts Response of Bone Mineral Density - Chesnut CH III, et al.
Abstracts Being Presented at the 2nd Annual Joint Meeting of ASBMR and IBMS
Thyroid Dysfunctional State Detected by QUS Measurements at Multiple Skeletal Sites
Discrimination of Vertebral fractures by QUS Measurements Performed At Multiple skeletal sites
Osteoporosis Supplement reprinted with permission of The Female Patient
Risk Factors for Osteoporosis in Reproductive-Age Women, - Chaim Putterman, MD
Women at Risk: The Premenopausal Years, - Abby Goulder Abelson, MD
Counseling premenopausal patients on lifestyle habits to promote bone health, as well as identifying nonmodifiable risk factors, can help prevent the devastating consequences of osteoporosis later in life.Pharmacotherapeutic Options, - Charles H. Chesnut III, MD
Here the author discusses currently available detection and treatment methods, delineating the distinction between bone quantity and bone quality.CME Test (in PDF format)
Advances in the Prevention and Management of Osteoporosis - Sydney Lou Bonnick, MD
Don't Wait for a Fracture: Identifying Osteoporosis - Richard D. Wasnich, MD
Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women - Aki Vainionpää, Raija Korpelainen, Juhani Leppäluoto & Timo Jämsä (in PDF format 240kb)
Additional Information
A simple clinical score for estimating the long-term risk of fracture in post-menopausal women - T. P. van Staa, P. Geusens, J. A. Kanis, H. G. M. Leufkens, S. Gehlbach, & C. Cooper
Guideline Updates:
Management and prevention of osteoporosis
Hip fracture: mortality rate
Menopause and hormone therapy (HT): collaborative decision-making and management: the percentage of women in menopause who have had a bone mineral density (BMD) measurement a year after cessation of HT
Information for Women about Osteoporosis and Other Bone Diseases
Management of Osteoporosis in Postmenopausal Women: 2006 position statement of The North American Menopause Society
Hormone replacement therapy and risk of hip fracture
Osteoporosis - Kendra Kaye Zuckerman, MD
Dual Energy X-Ray Absorptiometry (DEXA or DXA)- Margie Bissinger, MS, PT, Craig Bissinger, MD
Quantitative Heel Ultrasound as a Predictor for Osteoporosis
New Discoveries in Therapeutics: The Latest in Diagnostics - Barry L. Gruber, MDCalcium Supplementation, Hormone Replacement Therapy, and Osteoporosis
An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women
Weight and Body Mass Index at Menarche are Associated with Premenopausal Bone Mass
FDA Endocrinologic and Metabolic Drugs Advisory Committee Briefing on Forteo
Guidelines of Care on Osteoporosis for the Primary Care Physician
New Discoveries in Therapeutics: The Latest in Diagnostics - Barry L. Gruber, MD

Articles
Register for 